Page 5 - Tobin Schilke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tobin schilke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tobin Schilke Today - Breaking & Trending Today

Revance Therapeutics (NASDAQ:RVNC) Issues Earnings Results, Misses Expectations By $0.08 EPS

Revance Therapeutics (NASDAQ:RVNC – Get Free Report) released its earnings results on Tuesday. The biopharmaceutical company reported ($0.80) earnings per share for the quarter, missing the consensus estimate of ($0.72) by ($0.08), Briefing.com reports. Revance Therapeutics had a negative net margin of 224.65% and a negative return on equity of 1,091.00%. The company had revenue […] ....

Piper Sandler , Markj Foley , Tobin Schilke , Needham Company , Securities Exchange Commission , Advisor Group Holdings Inc , Money Concepts Capital Corp , Revance Therapeutics Inc , Life Insurance Co , Tower Research Capital , Revance Therapeutics , Get Free Report , Exchange Commission , Concepts Capital Corp , Group Holdings , Research Capital , Systematic Financial Management , Revance Therapeutics Daily , Nasdaq Rvnc ,

Revance Therapeutics, Inc. (NASDAQ:RVNC) Position Increased by Essex Investment Management Co. LLC

Essex Investment Management Co. LLC increased its position in shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 59.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,613 shares of the biopharmaceutical company’s stock after acquiring an […] ....

United States , Tobin Schilke , Markj Foley , Piper Sandler , Needham Company , Essex Investment Management Co , Securities Exchange Commission , Life Insurance Co , Revance Therapeutics Inc , Exchange Commission , Advisors Inc , Advisor Group Holdings Inc , Money Concepts Capital Corp , Essex Investment Management , Revance Therapeutics , Free Report , Investment Management , Concepts Capital Corp , Group Holdings , Metropolitan Life Insurance , Life Insurance , Get Free Report , Revance Therapeutics Daily , Nasdaq Rvnc , Sec Filings , Hedge Fund Holdings ,

Revance Therapeutics, Inc. (NASDAQ:RVNC) CFO Sells $42,593.04 in Stock

Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) CFO Tobin Schilke sold 1,701 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $25.04, for a total value of $42,593.04. Following the completion of the transaction, the chief financial officer now owns 79,896 shares of […] ....

United States , Tobin Schilke , Piper Sandler , Advisor Group Holdings Inc , Advisors Inc , Money Concepts Capital Corp , Revance Therapeutics Company Profile , Needham Company , Revance Therapeutics Inc , Revance Therapeutics , Free Report , Concepts Capital Corp , Group Holdings , Revance Therapeutics Daily , Nasdaq Rvnc , Insider Trading , Nsider Trades ,

Denali Advisors LLC Trims Stake in Revance Therapeutics, Inc. (NASDAQ:RVNC)

Denali Advisors LLC reduced its position in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 52.2% during the first quarter, HoldingsChannel.com reports. The firm owned 1,100 shares of the biopharmaceutical company’s stock after selling 1,200 shares during the period. Denali Advisors LLC’s holdings in Revance Therapeutics were worth $35,000 at the end of the most […] ....

United States , Tobin Schilke , Piper Sandler , Revance Therapeutics Inc , Needham Company , Ae Wealth Management , Securities Exchange Commission , Perfromance Wealth Partners , Wells Fargo Company , Revance Therapeutics Company Profile , Denali Advisors , Advisors Inc , Revance Therapeutics , Free Report , Wealth Partners , Exchange Commission , Visit Holdingschannel , Revance Therapeutics Daily ,

Waypoint Capital Advisors LLC Buys 37,000 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC)

Waypoint Capital Advisors LLC raised its stake in shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Rating) by 68.5% during the 1st quarter, HoldingsChannel.com reports. The firm owned 90,989 shares of the biopharmaceutical company’s stock after acquiring an additional 37,000 shares during the quarter. Waypoint Capital Advisors LLC’s holdings in Revance Therapeutics were worth $2,930,000 […] ....

United States , Piper Sandler , Carey Oconnor Kolaja , Tobin Schilke , Securities Exchange Commission , Jacobs Levy Equity Management Inc , Revance Therapeutics Company Profile , Commonwealth Equity Services , Needham Company , Flaharty Asset Management , Blair William Co , Revance Therapeutics Inc , Waypoint Capital Advisors , Wells Fargo Company , Revance Therapeutics , Get Rating , Capital Advisors , Equity Services , Levy Equity Management , Mahoney Asset Management , Asset Management , Director Carey Oconnor Kolaja , Exchange Commission , Visit Holdingschannel , Revance Therapeutics Daily , Nasdaq Rvnc ,